XML 40 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Segments (Tables)
 6 Months Ended
Jun. 30, 2017
Segment Reporting [Abstract]  
Operations and Assets for Operating Segments and Geographic Information
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended June 30,
 
For the six months ended June 30,
(In thousands)
2017
 
2016
 
2017
 
2016
Revenue from services:
 
 
 
 
 
 
 
Pharmaceutical
$
—

 
$
—

 
$
—

 
$
—

Diagnostics
256,671

 
266,012

 
511,956

 
518,534

Corporate
—

 
—

 
—

 
—

 
$
256,671

 
$
266,012

 
$
511,956

 
$
518,534

Revenue from products:
 
 
 
 
 
 
 
Pharmaceutical
$
28,966

 
$
22,807

 
$
51,197

 
$
42,706

Diagnostics
—

 
—

 
—

 
—

Corporate
—

 
—

 
—

 
—

 
$
28,966

 
$
22,807

 
$
51,197

 
$
42,706

Revenue from transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceutical
$
28,576

 
$
68,281

 
$
47,154

 
$
86,898

Diagnostics
—

 
—

 
—

 
—

Corporate
—

 
—

 
—

 
—

 
$
28,576

 
$
68,281

 
$
47,154

 
$
86,898

Operating income (loss):
 
 
 
 
 
 
 
Pharmaceutical
$
(8,621
)
 
$
35,345

 
$
(31,258
)
 
$
34,015

Diagnostics
(4,944
)
 
10,374

 
(8,044
)
 
8,019

Corporate
(12,878
)
 
(17,453
)
 
(28,849
)
 
(41,286
)
 
$
(26,443
)
 
$
28,266

 
$
(68,151
)
 
$
748

Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceutical
$
6,694

 
$
2,987

 
$
13,469

 
$
5,848

Diagnostics
18,827

 
21,573

 
37,752

 
40,893

Corporate
30

 
20

 
60

 
39

 
$
25,551

 
$
24,580

 
$
51,281

 
$
46,780

Income (loss) from investment in investees:
 
 
 
 
 
 
 
Pharmaceutical
$
(5,309
)
 
$
391

 
$
(7,123
)
 
$
(4,430
)
Diagnostics
(319
)
 
(2,379
)
 
(635
)
 
97

Corporate
—

 
—

 
—

 
—

 
$
(5,628
)
 
$
(1,988
)
 
$
(7,758
)
 
$
(4,333
)
Revenues:
 
 
 
 
 
 
 
United States
$
266,874

 
$
266,044

 
$
522,514

 
$
518,482

Ireland
21,913

 
71,789

 
42,630

 
93,932

Chile
11,899

 
9,597

 
22,020

 
16,580

Spain
5,118

 
4,324

 
9,623

 
8,347

Israel
7,654

 
4,420

 
11,872

 
9,162

Mexico
724

 
926

 
1,589

 
1,635

Other
31

 
—

 
59


—

 
$
314,213

 
$
357,100

 
$
610,307

 
$
648,138


(In thousands)
June 30,
2017
 
December 31,
2016
Assets:
 
 
 
Pharmaceutical
$
1,294,645

 
$
1,294,916

Diagnostics
1,380,849

 
1,408,522

Corporate
93,200

 
63,181

 
$
2,768,694

 
$
2,766,619

Goodwill:

 

Pharmaceutical
$
259,288

 
$
251,817

Diagnostics
452,787

 
452,786

Corporate
—

 
—

 
$
712,075

 
$
704,603